Our breakthrough multiplex particle - a flexible toolkit to tailor performance advantages for unique therapeutic applications.

Delivered in our proprietary platform which harnesses the properties of self-amplifying RNA and synthetic genomics to engineer novel RNA therapeutics.

This unique, biosynthetic multiplex nanoparticle lets us target, deliver and control gene expression. 

A powerful approach for the development and delivery of better therapeutics and vaccines with dose advantage, more durable protein expression, larger payload and multi-gene delivery.